Your browser doesn't support javascript.
loading
To Treat or Not to Treat?
Levine, Steven R; Weingast, Sarah Z; Weedon, Jeremy; Stefanov, Dimitre G; Katz, Patricia; Hurley, Dana; Kasner, Scott E; Khatri, Pooja; Broderick, Joseph P; Grotta, James C; Feldmann, Edward; Panagos, Peter D; Romano, Jose G; Bianchi, Riccardo; Meyer, Brett C; Scott, Phillip A; Kim, Doojin; Balucani, Clotilde.
Afiliación
  • Levine SR; From the Departments of Neurology and Emergency Medicine (S.R.L.).
  • Weingast SZ; Department of Neurology, Kings County Medical Center, Brooklyn, NY (S.R.L.).
  • Weedon J; Department of Neurology (S.Z.W., C.B.).
  • Stefanov DG; Department of Scientific Computing (J.W., D.G.S.).
  • Katz P; Department of Scientific Computing (J.W., D.G.S.).
  • Hurley D; Department of Medicine, University of California San Francisco (P. Katz).
  • Kasner SE; Genentech, Inc, Seattle, WA (D.H.).
  • Khatri P; Department of Neurology, University of Pennsylvania, Philadelphia (S.E.K.).
  • Broderick JP; Department of Neurology, University of Cincinnati, OH (P. Khatri, J.P.B.).
  • Grotta JC; Department of Neurology, University of Cincinnati, OH (P. Khatri, J.P.B.).
  • Feldmann E; Department of Neurology, Memorial Hermann Hospital-Texas Medical Center, Houston (J.C.G.).
  • Panagos PD; Department of Neurology, UMass Medical School-Baystate, Springfield, MA (E.F.).
  • Romano JG; Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO (P.D.P.).
  • Bianchi R; Department of Neurology, University of Miami, FL (J.G.R.).
  • Meyer BC; Department of Physiology and Pharmacology (R.B.), SUNY Downstate Medical Center, Brooklyn, NY.
  • Scott PA; Department of Neurology, UC San Diego Health, CA (B.C.M.).
  • Kim D; Department of Emergency Medicine, University of Michigan, Ann Arbor (P.A.S.).
  • Balucani C; Department of Emergency Medicine, David Geffen School of Medicine at UCLA, Santa Monica, CA (D.K.).
Stroke ; 49(8): 1933-1938, 2018 08.
Article en En | MEDLINE | ID: mdl-29976582
Background and Purpose- The 2015 updated US Food and Drug Administration alteplase package insert altered several contraindications. We thus explored clinical factors influencing alteplase treatment decisions for patients with minor stroke. Methods- An expert panel selected 7 factors to build a series of survey vignettes: National Institutes of Health Stroke Scale (NIHSS), NIHSS area of primary deficit, baseline functional status, previous ischemic stroke, previous intracerebral hemorrhage, recent anticoagulation, and temporal pattern of symptoms in first hour of care. We used a fractional factorial design (150 vignettes) to provide unconfounded estimates of the effect of all 7 main factors, plus first-order interactions for NIHSS. Surveys were emailed to national organizations of neurologists, emergency physicians, and colleagues. Physicians were randomized to 1 of 10 sets of 15 vignettes, presented randomly. Physicians reported the subjective likelihood of giving alteplase on a 0 to 5 scale; scale categories were anchored to 6 probabilities from 0% to 100%. A conjoint statistical analysis was applied. Results- Responses from 194 US physicians yielded 156 with complete vignette data: 74% male, mean age 46, 80% neurologists. Treatment mean probabilities for individual vignettes ranged from 6% to 95%. Treatment probability increased from 24% for NIHSS score =1 to 41% for NIHSS score =5. The conjoint model accounted for 25% of total observed response variance. In contrast, a model accounting for all possible interactions accounted for 30% variance. Four of the 7 factors accounted jointly for 58% of total relative importance within the conjoint model: previous intracerebral hemorrhage (18%), recent anticoagulation (17%), NIHSS (13%), and previous ischemic stroke (10%). Conclusions- Four main variables jointly account for only a small fraction (<15%) of the total variance related to deciding to treat with intravenous alteplase, reflecting high variability and complexity. Future studies should consider other variables, including physician characteristics.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos / Terapia Trombolítica / Encuestas y Cuestionarios / Activador de Tejido Plasminógeno / Accidente Cerebrovascular / Toma de Decisiones Clínicas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Stroke Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos / Terapia Trombolítica / Encuestas y Cuestionarios / Activador de Tejido Plasminógeno / Accidente Cerebrovascular / Toma de Decisiones Clínicas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Stroke Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos